1.Optimising Strategy of Transfer Network in Critical Neonatus
lan, XU ; ai-li, XU ; guo-ying, TANG ; yu-ming, ZHANG
Journal of Applied Clinical Pediatrics 1992;0(06):-
Objective To explore the role of transfer network in critical neonatus treatment and its optimising strategy.Methods All the materials of critical neonatus who were transferred by network between Jan.2004 and Dec.2007 were collected,the establishment and mechanism of transfer network service,the change of transfer models,results and main factors influencing effect of transfer network in this pe-riod were analyzed.Software SPSS 11.0 was used to analyze the data.Results Two hundred and fifty-six critical neonatus cases were transferred by network between Jan.2004 and Dec.2007,accounting for 13.79% in all critical neonatus born in this period.The birth rate of critical neonatus decreased each year and also the proportion of transfer.The proportion significantly reduced during 2006-2007 compared with that in 2004-2005(P
2.Linkage analysis of congenital nuclear cataract and DLAD locus
Lin-Lin, CHEN ; Ai-Lan, TANG ; Xue, ZHANG ; Jin-Song, ZHANG
International Eye Science 2005;5(4):625-627
· AIM: DLAD (DnaseII-like acid Dnase) is an acid DNase that is highly expressed in human and murine lens fibre cells. Recently, the DLAD-/- mice with a deficience in DLAD gene were reported to develop nuclear cataract.To elucidate whether a deficient DLAD gene can cause some human cataract, we studied autosomal dominant nuclear catarat in 6 families and analysed linkage between cataract and DLAD locus.·METHODS: Two-point Lod score values were obtained for markers D1S551 and GATA65B07.· RESULTS: The results show negative Lod scores (z=-∞ at θ =0), so linkage was excluded between the defect and DLAD locus in these families.·CONCLUSION: no evidence for cataracts in these families linkage to chromosome 1p22.3, the DLAD locus.
3.Determination of six C-Glycoside flavones and antitumor activity of water-soluble total flavonoids from Isodon lophanthoides var. gerardianus.
Yang ZHANG ; Hai-ming TANG ; Ai LI ; Lan-fang XU ; Jian-nan CHEN ; Song HUANG ; Lian HE
China Journal of Chinese Materia Medica 2015;40(8):1543-1547
This research established an HPLC method for determination of six C-Glycoside flavones of warer-soluble total flavonoids from Isodon lophanthoides var. gerardianus (Benth.) H. Hara, and studied the antitumor activity of the warer-soluble total flavonoids. The HPLC system consisted of Kromasil 100-5 C18 (4.6 mm x 250 mm, 5 microm) column and a solution system of methanol, acetonitrile and 0.5% formic acid gradient elution at a flow rate of 0. 8 mL x min(-1) and the wavelength of detector was at 334 nm. The column temperature was 25 degrees C. The antitumor activity of water-soluble flavonoids was assayed using HepG2 cell as the tested cell. The linear ranges of vicenin II, vicenin III, isoschaftoside, schaftoside, vitexin, 6, 8-di-C-a-L-arabinosylapigenin were 0.25-2.53, 0.12-1.20, 0.37-3.69, 0.16-1.63, 0.19-1.92, 0.14-1.42 microg, respectively. The average recoveries (n = 6) were 99.6% (RSD 0.87%), 100.2% (RSD 2.0%), 99.6% (RSD 1.8%), 97.9% (RSD 1.5%), 98.8% (RSD 1.2%), 98.6% (RSD 1.2%), respectively. After exposure in 24, 48, 72 h, the total flavonoids showed inhibitory effect on the proliferation of HepG2 cells with IC50 as the evaluation index, the IC50 values of 1.89, 1.71, 1.51 g x L(-1), respectively. The method is quick, simple and accurate with good re- producibility, and can be used for determination of vicenin II, vicenin III, isoschaftoside, schaftoside, vitexin, 6, 8-di-C-a-L-arabino- sylapigenin in the warer-soluble total flavonoids from L lophanthoides var. gerardianus. The warer-soluble total flavonoids from L lophanthoides have inhibitory effect on the proliferation of HepG2 cells.
Antineoplastic Agents, Phytogenic
;
analysis
;
pharmacology
;
Cell Line, Tumor
;
Cell Proliferation
;
drug effects
;
Chromatography, High Pressure Liquid
;
Drugs, Chinese Herbal
;
analysis
;
pharmacology
;
Flavones
;
analysis
;
pharmacology
;
Humans
;
Isodon
;
chemistry
;
Monosaccharides
;
analysis
;
pharmacology
4.Stability analysis of reference gene based on real-time PCR in Artemisia annua under cadmium treatment.
Liang-Yun ZHOU ; Ge MO ; Sheng WANG ; Jin-Fu TANG ; Hong YUE ; Lu-Qi HUANG ; Ai-Juan SHAO ; Lan-Ping GUO
China Journal of Chinese Materia Medica 2014;39(5):777-784
In this study, Actin, 18S rRNA, PAL, GAPDH and CPR of Artemisia annua were selected as candidate reference genes, and their gene-specific primers for real-time PCR were designed, then geNorm, NormFinder, BestKeeper, Delta CT and RefFinder were used to evaluate their expression stability in the leaves of A. annua under treatment of different concentrations of Cd, with the purpose of finding a reliable reference gene to ensure the reliability of gene-expression analysis. The results showed that there were some significant differences among the candidate reference genes under different treatments and the order of expression stability of candidate reference gene was Actin > 18S rRNA > PAL > GAPDH > CPR. These results suggested that Actin, 18S rRNA and PAL could be used as ideal reference genes of gene expression analysis in A. annua and multiple internal control genes were adopted for results calibration. In addition, differences in expression stability of candidate reference genes in the leaves of A. annua under the same concentrations of Cd were observed, which suggested that the screening of candidate reference genes was needed even under the same treatment. To our best knowledge, this study for the first time provided the ideal reference genes under Cd treatment in the leaves of A. annua and offered reference for the gene expression analysis of A. annua under other conditions.
Artemisia annua
;
drug effects
;
genetics
;
metabolism
;
Cadmium
;
pharmacology
;
Plant Leaves
;
drug effects
;
genetics
;
metabolism
;
Plant Proteins
;
genetics
;
metabolism
;
Real-Time Polymerase Chain Reaction
;
methods
;
standards
;
Reference Standards
5.Supination-reset method for the treatment of Smith fracture.
Lan-sheng MA ; Xue-feng DAII ; Rong-hui WAN ; Feng XU ; Ai-ke TANG
China Journal of Orthopaedics and Traumatology 2011;24(2):173-173
Adolescent
;
Adult
;
Aged
;
Child
;
Colles' Fracture
;
physiopathology
;
therapy
;
Female
;
Follow-Up Studies
;
Humans
;
Male
;
Manipulation, Orthopedic
;
methods
;
Middle Aged
;
Supination
;
Treatment Outcome
;
Young Adult
6.A Chinese girl with cleidocranial dysplasia (CCD) caused by the recurrent R190W mutation in RUNX 2.
Zheng-qing QIU ; Ai-lan TANG ; Wei YU ; Yang AO ; H Y Lo WILSON ; Min WEI ; Xue ZHANG
Chinese Journal of Pediatrics 2004;42(10):759-761
OBJECTIVECleidocranial dysplasia (CCD) is a rare skeletal disease with autosomal dominant inheritance associated with mutation in RUNX 2. The authors report a Chinese girl with CCD in whom the mutation in RUNX 2 was identified.
METHODSClinical diagnosis was based on physical examination, radiological findings, and biochemical tests. For mutation detection, genomic DNA was extracted from peripheral blood using standard method. All 7 coding exons of RUNX 2 and their flanking intronic sequences were amplified by polymerase chain reaction (PCR), and the PCR products were then subjected to automatic DNA sequencing.
RESULTSThe affected girl showed typical clinical manifestations of CCD, including patent fontanelles, absent clavicles, short stature and dental anomalies. Direct sequencing of PCR-amplified fragments revealed a recurrent missense mutation, R190W (568 C > T), in RUNX 2. The mutation was further confirmed by Hae III restriction analysis.
CONCLUSIONA Chinese case of CCD was confirmed and the disease-causing mutation was linked to a recurrent point mutation in RUNX 2.
Cleidocranial Dysplasia ; genetics ; Core Binding Factor Alpha 1 Subunit ; genetics ; Female ; Humans ; Mutation
7.Inhibition of survivin expression in liver cancer cells by shRNA.
Ge YAN ; Ai-long HUANG ; Ni TANG ; Bing-qian ZHANG ; Dan PU ; Ming-que XIANH ; Yin-hua LAN ; Gang WU
Chinese Journal of Hepatology 2003;11(12):712-715
OBJECTIVETo construct the plasmid containing short hairpin RNA (shRNA) of survivin in order to suppress the expression of survivin gene in HepG2 and SMMC-7721.
METHODSTwo 20 to 21 bp reverse repeated motifs of survivin target sequence with 4 bp or 8 bp spacer were synthesized respectively and inserted into plasmid pTZU6+1 to generate the plasmid pshRNA-survivin1 and pshRNA-survivin2; plasmid pEGFP-C1-survivin and pshRNA-survivin1 or pshRNA-survivin2 plasmid were cotransfected into liver cancer cell HepG2 and SMMC-7721 to detect effect of GFP expression respectively and analyze the inhibition of survivin gene.
RESULTSThe recombinant plasmid pshRNA-survivin1 and pshRNA-survivin2 were successfully constructed. The recombinant plasmids suppress the survivin expression by 80% in HepG2 and SMMC-7721.
CONCLUSIONThe result showed that the short hairpin RNA of survivin can efficiently suppress it's expression in HepG2 and SMMC-7721.
Gene Expression Regulation, Neoplastic ; Genetic Therapy ; Humans ; Inhibitor of Apoptosis Proteins ; Liver Neoplasms ; genetics ; therapy ; Microtubule-Associated Proteins ; genetics ; Neoplasm Proteins ; RNA Interference ; RNA, Small Interfering ; genetics
8.Effects of cytochrome P450 isozymes on aristolochic acid renal cytotoxicity.
Xi-lan TANG ; Ai-hua LIANG ; Chang-an YU ; Ting LIU ; Yong ZHAO ; Chun-yu CAO ; Chun-ying LI ; Yan YI ; Ran HAO
China Journal of Chinese Materia Medica 2008;33(17):2164-2169
OBJECTIVETo investigate the effect of cytochrome P450 isozymes on aristolochic acid induced cytotoxicity on renal proximal tubular epithelial cell (cell line HK-2).
METHODHuman renal tubular cells (cell line HK-2), were treated with aristolochic acid (AA) alone or in combination with cytochrome P450 isozymes inhibitors, including alpha-naphthoflavone (CYP450 1A1 and 1 A2 inhibitors), ketoconazole (CYP450 3A4 inhibitor), sodium diethyldithiocarbamate (CYP450 2A6 and 2E1 inhibitors), quinidine (CYP450 2D inhibitor), alpha-lipoic acid (NADPH: P450 reductase inhibitor), sulfaphenazole (CYP450 2C inhibitor) in the presence or absence of liver microsome(S9). The inhibition of cell proliferation rate was studied by MTT assay and the lactate dehydrogenase release rate was determined with continuous monitoring method.
RESULTAA inhibits cell proliferation and promotes the release of LDH over the range of 12.5-100 mg x L(-1), in a dose-dependent manner. Addition of S9 into the culture system reduced AA cytotoxicity, with the cell proliferation inhibition reducing and the release of LDH decreasing (AA + S9 group vs the same concentration of AA alone group, P < 0.05). In the absence of S9, ketoconazole or alpha-naphthoflavone has no obvious effect on AA cytotoxicity, however,under the conditions of adding S9, ketoconazole or alpha-naphthoflavone enhances AA cytotoxicity. Other inhibitors of CYP450 isozymes has no distinct effect on AA cytotoxicity.
CONCLUSIONThe microsomal enzyme of Liver can reduce the AA cytotoxicity, and CYP450 3A, CYP450 1A may be the major cytochrome P450 isozymes which impact AA cytotoxicity.
Animals ; Aristolochic Acids ; toxicity ; Cell Line ; Cell Proliferation ; drug effects ; Cytochrome P-450 Enzyme Inhibitors ; Cytochrome P-450 Enzyme System ; metabolism ; Cytotoxicity, Immunologic ; drug effects ; Enzyme Inhibitors ; pharmacology ; Humans ; Kidney Tubules ; drug effects ; enzymology ; immunology ; Male ; Rats ; Rats, Wistar
9.A new mutation in the GJB1 gene of a Chinese family with Charcot-Marie-Tooth disease associated with vocal cord paresis.
Qing-hua LI ; Kai-xiang LIU ; Jun-lin FENG ; Ai-yuan ZENG ; Hao LI ; Lan WU ; Yong-gang TANG ; Mei-lin CHEN ; Xiao-hui LIN ; Jing-zi JIANG
Chinese Journal of Medical Genetics 2010;27(5):497-500
OBJECTIVETo report an X-linked dominant Charcot-Marie-Tooth disease (CMTX) Chinese family with vocal cord paresis and to identify the mutation of gap junction protein beta 1 gene (GJB1).
METHODSPart of the family members with dysphagia, dysphonia and lethal respiratory failure were studied through flexible laryngoscope, clinical, brain MRI and electrophysiological examinations. After excluding large fragment tandem duplication containing peripheral myelin protein 22 gene (PMP22), direct sequencing was performed to analyze the mutation of the GJB1 gene in 5 patients including the proband, 5 unaffected family members and 50 unrelated healthy individuals.
RESULTSEight members spanning 3 generations in this family were affected with CMTX characterized by progressive atrophy and weakness of the anterior tibial and peroneal muscles, especially in the proband. Vocal cord paresis was observed through flexible laryngoscope in total of 4 affected members with dysarthria and dysphagia, 2 of them died of severe respiratory failure due to complete bilateral vocal cord involvement. Normal brain MRI was observed in the proband. The electrophysiological data showed predominant demyelization involving the motor and sensory nerves in the proband. DNA sequencing revealed a de novo c.186 C>G missense mutation in exon 2 of the GJB1 gene, the mutation cosegregated with phenotype.
CONCLUSIONRespiratory failure associated with vocal cord involvement may be a rare and severe symptom in CMTX. The present report provides further evidence for clinical and genetic heterogeneity in the X-linked Charcot-Marie-Tooth disease.
Adolescent ; Adult ; Asian Continental Ancestry Group ; genetics ; Base Sequence ; Case-Control Studies ; Charcot-Marie-Tooth Disease ; genetics ; Connexins ; genetics ; Female ; Humans ; Male ; Molecular Sequence Data ; Mutation, Missense ; Myelin Proteins ; genetics ; Pedigree ; Vocal Cord Paralysis ; genetics ; Young Adult
10.A preliminary study on the medical expenditure of Chinese medicine and integrative medicine treatment for influenza A (H1N1) in the fever clinics.
Chuan-jian LU ; Yi LUO ; Hong ZHOU ; Xiao-lan QIN ; Bo-jun CHEN ; Xue-chun TANG ; Hua DENG ; Zhao-hui LIANG ; Ai-hua OU
Chinese journal of integrative medicine 2010;16(6):493-497
OBJECTIVETo analyze the effectiveness of Chinese medicine and integrated Chinese and Western medicine for influenza A (H1N1) in the fever clinics and its relevant expenditure.
METHODSA prospective survey on the clinical epidemic observation and follow-up was conducted from July 2009 to October 2009 with a self-developed questionnaire whose contents including the clinical data of the confirmed 149 H1N1 cases and their relevant therapeutic expenditure. The patients were assigned to the Chinese medicine group (22 cases treated by Chinese medicine alone) and integrative medicine group (124 cases treated by both Chinese medicine and Western medicine). The data were processed with descriptive analysis, t test and χ (2), and sum-rank test.
RESULTSThe proportion of clinical recovery of Chinese medicine group (81.8%) was higher than that of integrative medicine group (54.8%) with statistical significance (P=0.02). The average fever durations in both groups were 3.5 to 4 days, showing no significant difference (P=0.86). In the comparisons of average cost of Chinese herbs, drugs, therapies, and total cost, those of the Chinese medicine group were lower than those in the integrative group (P=0.01, P=0.00, P=0.00, P=0.00).
CONCLUSIONSThe H1N1 patients in the fever clinic who received Chinese medicine treatment had a higher clinical recovery proportion than those who received integrated Chinese and Western medicine treatment with lower medical cost. However, due to small sample size of the Chinese medicine group in the study, the conclusion needs further confirmation by studies with large sample size.
Adult ; Costs and Cost Analysis ; Female ; Fever ; economics ; therapy ; virology ; Health Expenditures ; Hospitals ; Humans ; Influenza A Virus, H1N1 Subtype ; physiology ; Influenza, Human ; economics ; therapy ; virology ; Integrative Medicine ; economics ; Male ; Medicine, Chinese Traditional ; economics ; Time Factors ; Treatment Outcome